EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can Biomarkers Predict Kidney Function Recovery and Mortality in Patients with Critical COVID-19 and Acute Kidney Injury?

Noemí Del Toro-Cisneros, José C Páez-Franco iD, Miguel A Martínez-Rojas iD, Isaac González-Soria iD, Juan Antonio Ortega-Trejo iD, Hilda Sánchez-Vidal, Norma A Bobadilla iD, Alfredo Ulloa-Aguirre iD, Olynka Vega-Vega

Diagnostics · 05.08.2025 · 15 (15) · 1960

DOI: 10.3390/diagnostics15151960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 05.08.2025. Verfasst von Noemí Del Toro-Cisneros und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONACyT, Universidad Nacional Autónoma de México, Mexican Council of Science and Technology (CONACyT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: COVID-19 is a systemic viral infection that may lead to serious complications including acute kidney injury that requires kidney replacement therapy. The primary aim of this study was to evaluate urinary SerpinA3 (uSerpinA3) excretion as a biomarker of kidney recovery at 90 days, and the mortality in patients with critical COVID-19 and AKI requiring kidney replacement therapy (KRT).

Methods

The study included patients with critical COVID-19 on invasive mechanical ventilation (IMV) requiring KRT. Blood and urine samples were obtained when KRT was initiated (day zero), and thereafter on days 1, 3, 7, and 14 post-replacement. uSerpinA3, kidney injury molecule-1 (uKIM-1), and neutrophil gelatinase-associated lipocalin (uNGAL) were measured in urine, and interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor alpha (TNF-α) in peripheral blood. In addition, metabolomics in sample days zero and 3, and in the survivors on sample day 90 was performed by employing gas chromatography coupled with mass spectrometry.

Results

A total of 60 patients were recruited, of whom 29 (48%) survived hospitalization and recovered kidney function by day 90. In the survivors, 79% presented complete recovery (CRR) and the remaining (21%) recovered partially (PRR). In terms of uSerpinA3, levels on days 7 and 14 predicted CRR, with AUC values of 0.68 (p = 0.041) and 0.71 (p = 0.030), respectively, as well as mortality, with AUC values of 0.75 (p = 0.007) and 0.76 (p = 0.015), respectively. Among the other biomarkers, the excretion of uKIM-1 on day zero of KRT had a superior performance as a CRR predictor [(AUC, 0.71 (p = 0.017)], and as a mortality predictor [AUC, 0.68 (p = 0.028)]. In the metabolomics analysis, we identified four distinct profiles; the metabolite that maintained statistical significance in predicting mortality was p-cresol glucuronide.

Conclusions

This study strongly suggests that uSerpinA3 and uKIM-1 can predict CRR and mortality in patients with critical COVID-19 and AKI requiring KRT. Metabolic analysis appears promising for identifying affected pathways and their clinical impact in this population.

Schlagwörter

Stichwörter der Autor:innen

COVID-19acute kidney injurybiomarkersmortalityrenal recovery

Autor:innen und Institutionen

  • Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
  • Red de Apoyo a la Investigación, Universidad Nacional Autónoma de México, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
  • Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 14080, Mexico.

ORCID-Profile: José C Páez-Franco, Miguel A Martínez-Rojas, Isaac González-Soria, Juan Antonio Ortega-Trejo, Norma A Bobadilla, Alfredo Ulloa-Aguirre

Förderung

  • CONACyT
  • Universidad Nacional Autónoma de México
  • Mexican Council of Science and Technology (CONACyT)
  • Vida Noble

Zitieren

APA

Del Toro-Cisneros, N., Páez-Franco, J. C., Martínez-Rojas, M. A., González-Soria, I., Ortega-Trejo, J. A., Sánchez-Vidal, H., Bobadilla, N. A., Ulloa-Aguirre, A., & Vega-Vega, O. (2025). Can Biomarkers Predict Kidney Function Recovery and Mortality in Patients with Critical COVID-19 and Acute Kidney Injury?. Diagnostics, 15(15), 1960. https://doi.org/10.3390/diagnostics15151960

Vancouver

Del Toro-Cisneros N, Páez-Franco JC, Martínez-Rojas MA, González-Soria I, Ortega-Trejo JA, Sánchez-Vidal H, et al. Can Biomarkers Predict Kidney Function Recovery and Mortality in Patients with Critical COVID-19 and Acute Kidney Injury?. Diagnostics. 2025;15(15):1960. doi:10.3390/diagnostics15151960

BibTeX
@article{DelToroCisneros2025,
  author = {Del Toro-Cisneros, Noemí and Páez-Franco, José C and Martínez-Rojas, Miguel A and González-Soria, Isaac and Ortega-Trejo, Juan Antonio and Sánchez-Vidal, Hilda and Bobadilla, Norma A and Ulloa-Aguirre, Alfredo and Vega-Vega, Olynka},
  title = {Can Biomarkers Predict Kidney Function Recovery and Mortality in Patients with Critical COVID-19 and Acute Kidney Injury?},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {15},
  pages = {1960},
  doi = {10.3390/diagnostics15151960}
}
Kostenlos starten →